Ultralife Corporation
ULBI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $164,456 | $158,644 | $131,840 | $98,267 |
| % Growth | 3.7% | 20.3% | 34.2% | – |
| Cost of Goods Sold | $122,142 | $119,444 | $102,440 | $73,625 |
| Gross Profit | $42,314 | $39,200 | $29,400 | $24,642 |
| % Margin | 25.7% | 24.7% | 22.3% | 25.1% |
| R&D Expenses | $8,268 | $7,531 | $7,081 | $6,826 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $24,081 | $22,194 | $22,190 | $17,781 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $32,349 | $29,725 | $29,271 | $24,607 |
| Operating Income | $9,965 | $9,475 | $129 | $35 |
| % Margin | 6.1% | 6% | 0.1% | 0% |
| Other Income/Exp. Net | -$1,664 | -$358 | -$575 | -$186 |
| Pre-Tax Income | $8,301 | $9,117 | -$446 | -$151 |
| Tax Expense | $1,892 | $1,951 | -$326 | $79 |
| Net Income | $6,312 | $7,197 | -$119 | -$234 |
| % Margin | 3.8% | 4.5% | -0.1% | -0.2% |
| EPS | 0.38 | 0.44 | -0.007 | -0.015 |
| % Growth | -13.6% | 6,045.9% | 49.3% | – |
| EPS Diluted | 0.38 | 0.44 | -0.007 | -0.015 |
| Weighted Avg Shares Out | 16,555 | 16,357 | 16,125 | 16,037 |
| Weighted Avg Shares Out Dil | 16,767 | 16,226 | 16,125 | 16,037 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,940 | $2,016 | $951 | $242 |
| Depreciation & Amortization | $4,157 | $3,911 | $4,459 | $3,539 |
| EBITDA | $14,398 | $15,044 | $4,964 | $3,630 |
| % Margin | 8.8% | 9.5% | 3.8% | 3.7% |